Cutaneous Manifestations of Systemic Lupus Erythematosus

被引:73
作者
Uva, Luis [1 ]
Miguel, Diana [1 ]
Pinheiro, Catarina [1 ]
Freitas, Joao Pedro [1 ]
Gomes, Manuel Marques [1 ]
Filipe, Paulo [1 ]
机构
[1] Clin Univ Dermatol, Fac Med Lisboa, Ave Prof Egas Moniz, P-1649035 Lisbon, Portugal
关键词
D O I
10.1155/2012/834291
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Systemic lupus erythematosus (SLE) is a multiorgan autoimmune disease of unknown etiology with many clinical manifestations. The skin is one of the target organsmost variably affected by the disease. The American College of Rheumatology (ACR) established 11 criteria as a classificatory instrument to operationalise the definition of SLE in clinical trials. They were not intended to be used to diagnose individuals and do not do well in that capacity. Cutaneous lesions account for four of these 11 revised criteria of SLE. Skin lesions in patients with lupus may be specific or nonspecific. This paper covers the SLE-specific cutaneous changes: malar rash, discoid rash, photosensitivity, and oral mucosal lesions as well as SLE nonspecific skin manifestations, their pathophysiology, and management. A deeper thorough understanding of the cutaneous manifestations of SLE is essential for diagnosis, prognosis, and efficient management. Thus, dermatologists should cooperate with other specialties to provide optimal care of SLE patient.
引用
收藏
页数:16
相关论文
共 101 条
[1]   HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development [J].
Abdulahad, D. A. ;
Westra, J. ;
Limburg, P. C. ;
Kallenberg, C. G. M. ;
Bijl, M. .
AUTOIMMUNITY REVIEWS, 2010, 9 (10) :661-665
[2]   Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin [J].
Ahmed, A. Razzaque ;
Spigelman, Zachary ;
Cavacini, Lisa A. ;
Posner, Marshall R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (17) :1772-1779
[3]   Hair follicle stem cells in the pathogenesis of the scarring process in cutaneous lupus erythematosus [J].
Al-Refu, Khitam ;
Goodfield, Mark .
AUTOIMMUNITY REVIEWS, 2009, 8 (06) :474-477
[4]   The basement membrane zone in patients with systemic lupus erythematosus: immunofluorescence studies in the skin, kidney and amniochorion [J].
Alahlafi, AM ;
Wordsworth, P ;
Lakasing, L ;
Davies, D ;
Wojnarowska, F .
LUPUS, 2004, 13 (08) :594-600
[5]   The lupus band: do the autoantibodies target collagen VII? [J].
Alahlafi, AM ;
Wordsworth, P ;
Wojnarowska, F .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (03) :504-510
[6]   Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus [J].
Albrecht, J ;
Berlin, JA ;
Braverman, IM ;
Callen, JP ;
Costner, MI ;
Dutz, J ;
Fivenson, D ;
Franks, AG ;
Jorizzo, JL ;
Lee, LA ;
McCauliffe, DP ;
Sontheimer, RD ;
Werth, VP .
LUPUS, 2004, 13 (11) :839-849
[7]   Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus [J].
Albrecht, Joerg ;
Werth, Victoria P. .
DERMATOLOGIC THERAPY, 2007, 20 (02) :93-101
[8]  
ALRAWI Z, 1983, BRIT J RHEUMATOL, V22, P165
[9]   GAMMA-INTERFERON INDUCED HUMAN KERATINOCYTE HLA-DR SYNTHESIS - THE ROLE OF DERMAL ACTIVATED LYMPHOCYTES-T [J].
BARKER, JNWN ;
NAVSARIA, HA ;
LEIGH, IM ;
MACDONALD, DM .
BRITISH JOURNAL OF DERMATOLOGY, 1988, 119 (05) :567-572
[10]  
Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO